Clinical Trials Browser

Phase 2 × Lymphoma, Follicular × Crizotinib × Clear all

NCT02435108 2017-02-17

A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy

Phase 2 Completed

Lymphoma, Follicular